Diaceutics PLC
F:7DC

Watchlist Manager
Diaceutics PLC Logo
Diaceutics PLC
F:7DC
Watchlist
Price: 1.59 EUR Market Closed
Market Cap: €134.3m

Wall St Price Targets

7DC Price Targets Summary
Diaceutics PLC

Wall Street analysts forecast 7DC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 7DC is 2.63 EUR with a low forecast of 2.26 EUR and a high forecast of 2.99 EUR.

Lowest Forecast
Price Target
2.26 EUR
42% Upside
Average Forecast
Price Target
2.63 EUR
65% Upside
Highest Forecast
Price Target
2.99 EUR
88% Upside
Diaceutics PLC Competitors:
Price Targets
BARK
Bark Inc
49% Upside

Revenue
Forecast

23% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
23% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 8 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 3 years is 21%.

Gross Profit
Forecast

26% / Year
Past Growth
28% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
26% / Year
Past Growth
28% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 8 years, the compound annual growth rate for Gross Profit has been 26%. The projected CAGR for the next 2 years is 28%.

Operating Income
Forecast

-32% / Year
Past Growth
494% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat
-32% / Year
Past Growth
494% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat

Over the last 8 years, the compound annual growth rate for Operating Income has been -32%. The projected CAGR for the next 3 years is 494%.

Pre-Tax Income
Forecast

-11% / Year
Past Growth
316% / Year
Estimated Growth
Estimates Accuracy
12%
Average Beat
-11% / Year
Past Growth
316% / Year
Estimated Growth
Estimates Accuracy
12%
Average Beat

Over the last 8 years, the compound annual growth rate for Pre-Tax Income has been -11%. The projected CAGR for the next 2 years is 316%.

Net Income
Forecast

-21% / Year
Past Growth
477% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
-21% / Year
Past Growth
477% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

Over the last 8 years, the compound annual growth rate for Net Income has been -21%. The projected CAGR for the next 2 years is 477%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 7DC's stock price target?
Price Target
2.63 EUR

According to Wall Street analysts, the average 1-year price target for 7DC is 2.63 EUR with a low forecast of 2.26 EUR and a high forecast of 2.99 EUR.

What is the Revenue forecast for Diaceutics PLC?
Projected CAGR
21%

Over the last 8 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 3 years is 21%.

What is the Gross Profit forecast for Diaceutics PLC?
Projected CAGR
28%

Over the last 8 years, the compound annual growth rate for Gross Profit has been 26%. The projected CAGR for the next 2 years is 28%.

What is the Operating Income forecast for Diaceutics PLC?
Projected CAGR
494%

Over the last 8 years, the compound annual growth rate for Operating Income has been -32%. The projected CAGR for the next 3 years is 494%.

What is the Pre-Tax Income forecast for Diaceutics PLC?
Projected CAGR
316%

Over the last 8 years, the compound annual growth rate for Pre-Tax Income has been -11%. The projected CAGR for the next 2 years is 316%.

What is the Net Income forecast for Diaceutics PLC?
Projected CAGR
477%

Over the last 8 years, the compound annual growth rate for Net Income has been -21%. The projected CAGR for the next 2 years is 477%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett